A Phase I-II Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination with Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer
Age
14–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with diagnosed Metastatic Colorectal Cancer
You may not be if
Patients with diagnosis other than Metastatic Colorectal Cancer
